Sign In
Buy PBH
$50.22
+0.270 (+0.541%)
At Close: Jul 31, 2026
Prestige Brands (PBH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
04:33pm, Thursday, 30'th Jul 2020
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Prestige Consumer Healthcare (NYSE:PBH) Price Target Raised to $97.00
05:28am, Monday, 27'th Jul 2020
Prestige Consumer Healthcare (NYSE:PBH) had its price objective raised by TD Securities from $90.00 to $97.00 in a report issued on Friday morning, Stock Target Advisor reports. They currently have a
The Global Electrolyte Mixes Market will grow by $ 415.93 mn during 2019-2023
Trust Co. of Vermont Has $805,000 Position in Prestige Consumer Healthcare Inc (NYSE:PBH)
06:54am, Sunday, 19'th Jul 2020
Trust Co. of Vermont lowered its position in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 12.3% in the second quarter, according to the company in its most recent disclosure with the SEC.
Prestige Consumer Healthcare (NYSE:PBH) vs. Zai Lab (NYSE:ZLAB) Critical Survey
02:00am, Tuesday, 14'th Jul 2020
Prestige Consumer Healthcare (NYSE:PBH) and Zai Lab (NASDAQ:ZLAB) are both consumer discretionary companies, but which is the better stock? We will compare the two companies based on the strength of t
Prestige Consumer Healthcare Inc. to Release Fiscal 2021 First Quarter Earnings Results
08:45pm, Monday, 13'th Jul 2020
TARRYTOWN, N.Y., July 13, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 first quarter earnings release on Thursday, August 6,
Voloridge Investment Management LLC Cuts Holdings in Prestige Consumer Healthcare Inc (NYSE:PBH)
08:07am, Saturday, 04'th Jul 2020
Voloridge Investment Management LLC decreased its position in Prestige Consumer Healthcare Inc (NYSE:PBH) by 54.0% in the first quarter, according to its most recent Form 13F filing with the SEC. The
OHR Pharmaceutical (NASDAQ:OHRP) and Prestige Consumer Healthcare (NASDAQ:PBH) Critical Analysis
01:50am, Saturday, 04'th Jul 2020
Prestige Consumer Healthcare (NYSE:PBH) and OHR Pharmaceutical (NASDAQ:OHRP) are both small-cap consumer discretionary companies, but which is the superior business? We will compare the two companies
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), today announced it will join the Exelixis and Roche clinical collaboration and participate in the
GSK trionfa ai Consumer Healthcare Creative Awards di Teads | Engage
03:36pm, Tuesday, 30'th Jun 2020
Teads annuncia i vincitori dei Consumer Healthcare Creative Awards, i premi che celebrano l’impegno creativo per strategie digitali mobile nel settore CHC
Why Prestige Consumer Healthcare Is Struggling In The New COVID-19 E-Commerce Centric World
02:40pm, Tuesday, 30'th Jun 2020
Prestige Consumer Healthcare is non-value accretive roll-up of OTC Healthcare consumer products. In the new COVID-19 env't, we believe it is a net-loser due to
IPSEN S A/S (OTCMKTS:IPSEY) Shares Pass Above 200 Day Moving Average of $18.44
01:50am, Friday, 26'th Jun 2020
Shares of IPSEN S A/S (OTCMKTS:IPSEY) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $18.44 and traded as high as $20.67. IPSEN S A/S sh
Two Sigma Investments LP Takes Position in Prestige Consumer Healthcare Inc (NYSE:PBH)
07:32am, Thursday, 25'th Jun 2020
Two Sigma Investments LP purchased a new stake in Prestige Consumer Healthcare Inc (NYSE:PBH) in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Comm
Prestige Consumer Healthcare Inc. (PBH): Hedge Funds Are Coming Back
05:07pm, Wednesday, 24'th Jun 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
